4601 - 4650 of 8587 Results
Title
Year
- Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein2021OPENTitle: Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synucleinJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01283-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-021-01283-7Citation Count: 21
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12818.2Best OA location URL: https://mniopenresearch.org/articles/3-2/v2/pdfCitation Count: 0
-
OPENTitle: Measurement of chemosensory functionJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 4Issue #: 1Start Page: 11End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.wjorl.2018.03.001Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2095881118300222?via%3DihubCitation Count: 55
- Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies2019OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 35
-
OPENTitle: Gender Differences in the Prevalence of Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 86End Page: 93Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13584Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13584Citation Count: 41
- Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement2021RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: A high-resolution map of the human small non-coding transcriptomeJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 10Start Page: 1621End Page: 1628Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/34/10/1621/25118245/btx814.pdfCitation Count: 26
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates2017OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 40
- Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration2025OPENTitle: Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegenerationJournal Name: Fluids and Barriers of the CNSPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12987-025-00646-9Best OA location URL: https://fluidsbarrierscns.biomedcentral.com/counter/pdf/10.1186/s12987-025-00646-9Citation Count: 0
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 170
- Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease2018OPENTitle: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 1025End Page: 1035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.006Citation Count: 53
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://cdn.elifesciences.org/articles/91645/elife-91645-v2.pdfCitation Count: 28
- SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria2016OPENTitle: SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondriaJournal Name: Data in BriefPublisher: Elsevier BVVol: 9Issue #:Start Page: 589End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.dib.2016.09.031Best OA location URL: https://doi.org/10.1016/j.dib.2016.09.031Citation Count: 12
-
OPENTitle: Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 62Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-025-04996-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-025-04996-1.pdfCitation Count: 0
-
OPENTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.06.007Citation Count: 20
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021OPENTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.36866/123.32Best OA location URL: https://static.physoc.org/app/uploads/2021/09/29101854/PN123_2709_WEB_FINAL.pdfCitation Count: 0
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease2022OPENTitle: Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00300-3Best OA location URL: https://www.nature.com/articles/s41531-022-00300-3.pdfCitation Count: 25
- Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach2024OPENTitle: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental ApproachJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 1Start Page: 9End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms26010009Best OA location URL: https://www.mdpi.com/1422-0067/26/1/9/pdf?version=1735026493Citation Count: 4
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 42
- Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial2024OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 13
-
RESTRICTEDTitle: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005Citation Count: 3
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016OPENTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2016.06.003Citation Count: 22
-
OPENTitle: Association of mitochondrial genomic background with risk of Multiple System AtrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 200End Page: 204Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.040Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7769955Citation Count: 6
-
OPENTitle: Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast CancerJournal Name: Journal of OncologyPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5899728Best OA location URL: https://escholarship.org/content/qt9cj1h6h9/qt9cj1h6h9.pdfCitation Count: 1
-
OPENTitle: Cerebral chemoarchitecture shares organizational traits with brain structure and functionJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.83843Best OA location URL: https://cdn.elifesciences.org/articles/83843/elife-83843-v2.pdfCitation Count: 13
-
RESTRICTEDTitle: Motor patterns in Parkinson's disease: A data‐driven approachJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 7Start Page: 1042End Page: 1047Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22512Citation Count: 35
- Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial Finder2015OPENTitle: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial FinderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 5Issue #: 1Start Page: 55End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140522Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140522?id=journal-of-parkinsons-disease%2Fjpd140522Citation Count: 14
-
OPENTitle: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brainJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 26End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002Best OA location URL: https://doi.org/10.1016/j.nepig.2016.04.002Citation Count: 11
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein2016OPENTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 38
-
RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 156
-
OPENTitle: HFE H63D Limits Nigral Vulnerability to Paraquat in Agricultural WorkersJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 181Issue #: 1Start Page: 47End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfab020Best OA location URL: https://academic.oup.com/toxsci/article-pdf/181/1/47/37464453/kfab020.pdfCitation Count: 5
- Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study2017OPENTitle: Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: 811End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx376Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/811/25046389/awx376.pdfCitation Count: 135
- The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking2020OPENTitle: The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol traffickingJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 39Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.2019103791Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.15252/embj.2019103791Citation Count: 107
-
OPENTitle: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1100-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1100-1Citation Count: 148
-
OPENTitle: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 1Start Page: 51End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02585-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02585-x.pdfCitation Count: 18
-
OPENTitle: Structural basis for feedforward control in the PINK1/Parkin pathwayJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2021109460Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2021109460Citation Count: 21
- Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-Selective2015RESTRICTEDTitle: Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-SelectiveJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 959End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi501512mCitation Count: 56
- DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease2024OPENTitle: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s diseaseJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page: 4349End Page: 4371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01116-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11357-024-01116-0.pdfCitation Count: 11
- Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease2018OPENTitle: Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1501End Page: 1516Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awy072Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/97261272/Nucleus_basalis_of_Meynert_SCHULZE_Accepted29January2018_GREEN_AAM.pdfCitation Count: 189
-
OPENTitle: ALS‐linked protein disulfide isomerase variants cause motor dysfunctionJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 8Start Page: 845End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201592224Best OA location URL: http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=3455855Citation Count: 108
- CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease2021OPENTitle: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 7Start Page: 2047End Page: 2059Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awab103Best OA location URL: https://academic.oup.com/brain/article-pdf/144/7/2047/39769283/awab103.pdfCitation Count: 226
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://research.rug.nl/en/publications/2dd21a81-bba8-4531-aab2-e50105663eadCitation Count: 44
- Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis2023OPENTitle: Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosisJournal Name: Psychiatry and Clinical NeurosciencesPublisher: WileyVol: 77Issue #: 12Start Page: 665End Page: 671Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/pcn.13594Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/pcn.13594Citation Count: 8
- Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separation2020RESTRICTEDTitle: Protein quality control by the proteasome and autophagy: A regulatory role of ubiquitin and liquid-liquid phase separationJournal Name: Matrix BiologyPublisher: Elsevier BVVol: 100-101Issue #:Start Page: 9End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.matbio.2020.11.003Citation Count: 29
-
OPENTitle: Validation of human microRNA target pathways enables evaluation of target prediction toolsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 1Start Page: 127End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1161Best OA location URL: https://academic.oup.com/nar/article-pdf/49/1/127/35597117/gkaa1161.pdfCitation Count: 56
-
OPENTitle: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and DiseaseJournal Name: ReceptorsPublisher: MDPI AGVol: 3Issue #: 2Start Page: 155End Page: 181Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/receptors3020009Best OA location URL: https://www.mdpi.com/2813-2564/3/2/9/pdf?version=1712907165Citation Count: 26
- Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation2017OPENTitle: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in NeuroinflammationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 3Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5865080Citation Count: 67
- Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis2018OPENTitle: Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 32Start Page: 8209End Page: 8214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1801109115Best OA location URL: https://repositorio.uchile.cl/handle/2250/159191Citation Count: 98
-
OPENTitle: Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf146/62941156/fcaf146.pdfCitation Count: 0